Hypnotherapy as an Adjuvant for the Management of Inflammatory Bowel Disease: A Case Report

American Journal of Clinical Hypnosis

Volumn 51, Issue 3, 2009, Pages 255-262

  Emami, Mohammad Hassan ^a   Gholamrezaei, Ali ^a,b   Daneshgar, Houshang ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Poursina Hakim Research Institute   (Iran)

Author keywords

Complementary; Coping; Crohn's disease; Hypnotherapy; Inflammatory bowel disease; Psychological; Quality of life

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COPING BEHAVIOR; CROHN DISEASE; EGO; FEMALE; FOLLOW UP; HUMAN; IMAGINATION; PATIENT PARTICIPATION; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; REMISSION; THERAPY EFFECT; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; COMBINED MODALITY THERAPY; CROHN DISEASE; FEMALE; HUMANS; HYPNOSIS, ANESTHETIC; IMAGINATION; QUALITY OF LIFE; SUGGESTION; YOUNG ADULT;

EID: 59149107108     PISSN: 00029157     EISSN: 21600562     Source Type: Journal    
DOI: 10.1080/00029157.2009.10401675     Document Type: Article

References (42)

1. Bhatia, V. & Tandon, R. K. (2005). Stress and the gastrointestinal tract. Journal of Gastroenterology and Hepatology, 20, 332-339
2. Calvert, E.L., Houghton, L.A., Cooper, P., Morris, J., & Whorwell, PJ. (2002). Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology, 123, 1778-1785
3. Carter, M.J., Lobo, A.J., & Travis, S.P. (2004). Guidelines for the management of inflammatory bowel disease in adults. Gut, 53, Supplement 5, 6-16
4. Casellas, F., Alcala, M.J., Prieto, L., Miro, J.R., & Malagelada, J.R. (2004). Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. American Journal of Gastroenterology,99, 457-461
5. Collins, S.M. (2001). Stress and the Gastrointestinal Tract IV. Modulation of intestinal inflammation by stress: Basic mechanisms and clinical relevance. American journal of Physiology: Gastrointestinal and Liver Physiology, 280, G315-G318
6. Dowd, T.E. 2000, “Hypnosis induction,” in Cognitive hypnotherapy, 1st ed. (pp. 40-44). Lanham: A Janson Aronson Book
7. Drossman, D.A., Leserman, J., Mitchell, C.M., Li, Z. M., Zagami, E.A., & Patrick, D.L. (1991). Health status and health care use in persons with inflammatory bowel disease: A national sample. Digestive Diseases and Sciences, 36, 1746-1755
8. Duffy, L.C., Zielezny, M.A., Marshall, J.R., Weiser, M.M., Phillips, J.F., Byers, T.E., Calkins, B. M., Graham, S., & Ogra, P.L. (1991). Lag time between stress events and risk of recurrent episodes of inflammatory bowel disease. Epidemiology, 2, 141-145
9. Galeazzi, F., Luca, M.G., Lanaro, D., D’Inca, R., D’Odorico, A., Sturniolo, G. C., & Mastropaolo, G. (2001). Esophageal hyperalgesia in patients with ulcerative colitis: Role of experimental stress. American Journal of Gastroenterology, 96, 2590-2595
10. Garcia-Vega, E. & Fernandez-Rodriguez, C. (2004). A stress management program for Crohn’s disease. Behavior Research and Therapy, 42, 367-383
11. Gholamrezaei, A., Khanpour Ardestani, S. & Emami, M. H. (2006). Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review. Journal of Alternative and Complementary Medicine, 12, 517-527
12. Gholamrezaei, A. & Emami, M.H. (2008). How to put hypnosis into a placebo pill? Complementary Therapies in Medicine, 16, 52-54
13. Gonsalkorale, W.M. (2006). Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. International Journal of Clinical and Experimental Hypnosis, 54, 27-50
14. Gonsalkorale, W.M., Toner, B.B., & Whorwell, PJ. (2004). Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. Journal of Psychosomatic Research, 56, 271-278
15. Gruzelier, J., Smith, F., Nagy, A., & Henderson, D. (2001). Cellular and humoral immunity, mood and exam stress: The influences of self-hypnosis and personality predictors, International Journal of Psychophysiology, 42, 55-71
16. Gruzelier, J.H. (2002). A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress, 5, 147-163
17. Guthrie, E., Jackson, J., Shaffer, J., Thompson, D., Tomenson, B., & Creed, F. (2002). Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. American Journal of Gastroenterology, 97, 1994-1999
18. Han, S.W., McColl, E., Barton, J.R., James, P., Steen, I.N., & Welfare, M.R. (2005). Predictors of quality of life in ulcerative colitis: The importance of symptoms and illness representations. Inflammatory Bowel Diseases, 11, 24-34
19. Hanauer, S. B. (2006). Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflammatory Bowel Diseases, 12 Supplement 1, S3-S9
20. Heap, M. & Aravind, K.K. (2002). “Hypnosis for smoking cessation, weight reduction and insomnia,” in Hartland’s medical and dental hypnosis, 4th ed. (pp. 295-322). Churchill Livingstone, Edinburgh
21. Jensen, M.P. & Patterson, D.R. (2005). Control conditions in hypnotic-analgesia clinical trials: Challenges and recommendations. International Journal of Clinical and Experimental Hypnosis, 53, 170-197
22. Jones, H., Cooper, P., Miller, V., Brooks, N., & Whorwell, P. J. (2006). Treatment of non-cardiac chest pain: A controlled trial of hypnotherapy. Gut, 55, 1403-1408
23. Keefer, L., & Keshavarzian, A. (2007). Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: A brief communication. International Journal of Clinical and Experimental Hypnosis, 55, 457-466
24. Kiecolt-Glaser, J.K., Marucha, P.T., Atkinson, C., & Glaser, R. (2001). Hypnosis as a modulator of cellular immune dysregulation during acute stress. Journal of Consulting and Clinical Psychology, 69, 674-682
25. Kirsch, I., Montgomery, G., & Sapirstein, G. (1995). Hypnosis as an adjunct to cognitive-behavioral psychotherapy: A meta-analysis. Journal of Consulting and Clinical Psychology, 63, 214-220
26. Levenstein, S. (2004). Embracing complexity: What determines quality of life in inflammatory bowel disease? European Journal of Gastroenterology and Hepatology, 16, 1253-1255
27. Miller, V. & Whorwell, P.J. (2008). Treatment of inflammatory bowel disease: A role for hypnotherapy? International Journal of Clinical & Experimental Hypnosis, 56, 306-317
28. Milne, B., Joachim, G, & Niedhardt, J. (1986). A stress management programme for inflammatory bowel disease patients. Journal of Advanced Nursing, 11, 561-567
29. Minderhoud, I.M., Oldenburg, B., van Dam, P.S., & Berge Henegouwen, G.P. (2003). High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. American Journal of Gastroenterology, 98, 1088-1093
30. Minderhoud, I.M., Oldenburg, B., Wismeijer, J.A., Berge Henegouwen, G.P., & Smout, A.J. (2004). IBS-like symptoms in patients with inflammatory bowel disease in remission: Relationships with quality of life and coping behavior. Digestive Diseases and Sciences, 49, 469-474
31. Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosomatic Medicine, 66, 79-84
32. Montazeri, A., Vahdaninia, M., Ebrahimi, M., & Jarvandi, S. (2003). The Hospital Anxiety and Depression Scale (HADS): Translation and validation study of the Iranian version. Health and Quality of Life Outcomes,1, 14
33. Mussell, M., Bocker, U., Nagel, N., Olbrich, R., & Singer, M.V. (2003). Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: Exploratory study of effectiveness. Scandinavian Journal of Gastroenterology, 38, 755-762
34. Olness, K., Culbert, T., & Uden, D. (1989). Self-regulation of salivary immunoglobulin A by children. Pediatrics, 83, 66-71
35. Pizzi, L.T., Weston, C.M., Goldfarb, N.I., Moretti, D., Cobb, N., Howell, J. B., Infantolino, A., Dimarino, A. J., & Cohen, S. (2006). Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflammatory Bowel Diseases,12, 47-52
36. Ranjbaran, Z., Keefer, L., Farhadi, A., Stepanski, E., Sedighi, Sh., & Keshavarzian, A. (2006). Impact of sleep disturbances in inflammatory bowel disease. Journal of Gastroenterology andHepatology, 22, 1748-1753
37. Sainsbury, A. & Heatley, R.V. (2005). Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 21, 499-508
38. Schafer, D.W. (1997). Hypnosis and the treatment of ulcerative colitis and Crohn’s disease. American Journal of Clinical Hypnosis, 40, 111-117
39. Simren, M., Axelsson, J., Gillberg, R., Abrahamsson, H., Svedlund, J., & Bjornsson, E.S. (2002). Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. American Journal of Gastroenterology, 97, 389-396
40. Soderholm, J.D. & Perdue, M.H. (2001). Stress and gastrointestinal tract. II: Stress and intestinal barrier function. American Journal of Physiology, Gastrointestinal and Liver Physiology, 280, G7-G13
41. Stanley, R.O., Norman, T.R., & Barrows, G.D. (2001). Hypnosis in the management of stress and anxiety disorders. In G.D. Burrow, R.O. Stanley & P.B. Bloom, Eds., International Handbook of Clinical Hypnosis (pp. 11-128). Chichester: John Wiley & Sons
42. Talley, N. J., Owen, B. K., Boyce, P., & Paterson, K. (1996). Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. American Journal of Gastroenterology,91, 277-283